Michele Cavo
Michele Cavo
Professor of Hematology
Verified email at unibo.it
TitleCited byYear
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
13052014
Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ...
Leukemia 22 (2), 414, 2008
7232008
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem …
M Cavo, P Tacchetti, F Patriarca, MT Petrucci, L Pantani, M Galli, ...
The Lancet 376 (9758), 2075-2085, 2010
7032010
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A Dispenzieri, R Kyle, G Merlini, JS Miguel, H Ludwig, R Hajek, ...
Leukemia 23 (2), 215, 2009
6672009
Continuous lenalidomide treatment for newly diagnosed multiple myeloma
A Palumbo, R Hajek, M Delforge, M Kropff, MT Petrucci, J Catalano, ...
New England Journal of Medicine 366 (19), 1759-1769, 2012
6262012
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149, 2012
5862012
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label …
J San Miguel, K Weisel, P Moreau, M Lacy, K Song, M Delforge, L Karlin, ...
The lancet oncology 14 (11), 1055-1066, 2013
5482013
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma
M Cavo, E Zamagni, P Tosi, P Tacchetti, C Cellini, D Cangini, A De Vivo, ...
Blood 106 (1), 35-39, 2005
4842005
Revised international staging system for multiple myeloma: a report from International Myeloma Working Group
A Palumbo, H Avet-Loiseau, S Oliva, HM Lokhorst, H Goldschmidt, ...
Journal of clinical oncology 33 (26), 2863, 2015
4612015
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
L Benboubker, MA Dimopoulos, A Dispenzieri, J Catalano, AR Belch, ...
New England Journal of Medicine 371 (10), 906-917, 2014
4432014
Oral ixazomib, lenalidomide, and dexamethasone for multiple myeloma
P Moreau, T Masszi, N Grzasko, NJ Bahlis, M Hansson, L Pour, I Sandhu, ...
New England Journal of Medicine 374 (17), 1621-1634, 2016
4352016
Autologous transplantation and maintenance therapy in multiple myeloma
A Palumbo, F Cavallo, F Gay, F Di Raimondo, D Ben Yehuda, MT Petrucci, ...
New England Journal of Medicine 371 (10), 895-905, 2014
4072014
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and …
BB Bjorkstrand, P Ljungman, H Svensson, J Hermans, A Alegre, ...
Blood 88 (12), 4711-4718, 1996
4071996
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple …
A Palumbo, S Bringhen, D Rossi, M Cavalli, A Larocca, R Ria, M Offidani, ...
Journal of Clinical Oncology 28 (34), 5101-5109, 2010
4022010
Proteasome inhibitors in multiple myeloma: 10 years later
P Moreau, PG Richardson, M Cavo, RZ Orlowski, JF San Miguel, ...
Blood 120 (5), 947-959, 2012
3982012
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
A Palumbo, S Bringhen, AM Liberati, T Caravita, A Falcone, V Callea, ...
Blood 112 (8), 3107-3114, 2008
3942008
Allogeneic bone marrow transplantation in multiple myeloma
G Gahrton, S Tura, P Ljungman, C Belanger, L Brandt, M Cavo, T Facon, ...
New England Journal of Medicine 325 (18), 1267-1273, 1991
3931991
CLINICAL PERSPECTIVE
C Rapezzi, G Merlini, CC Quarta, L Riva, S Longhi, O Leone, F Salvi, ...
Circulation 120 (13), 1203-1212, 2009
3852009
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study
M Cavo, P Tosi, E Zamagni, C Cellini, P Tacchetti, F Patriarca, ...
Journal of clinical oncology 25 (17), 2434-2441, 2007
3662007
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The Lancet Oncology 17 (8), e328-e346, 2016
3632016
The system can't perform the operation now. Try again later.
Articles 1–20